Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to eliminate follow-up copays for cervical cancer diagnostic testing
Summary
The House Committee on Health Care voted to send Senate Bill 15 27 A to the floor with a do-pass recommendation after testimony that out-of-pocket costs for diagnostic follow-up (colposcopy, biopsy, pathology) discourage timely care. The committee voted unanimously in favor.
Senate Bill 15 27 A, which would require group and individual health plans as well as the Public Employees' Benefit Board and the Oregon Educators Benefit Board to cover medically necessary cervical cancer screenings and eliminate out-of-pocket costs for follow-up diagnostic testing, was advanced by the House Committee on Health Care on Wednesday.
The committee voted to send the bill to the House floor with a do-pass recommendation following testimony from its Senate sponsor and medical professionals who said follow-up costs can be prohibitively expensive. "Senate Bill 15 27 A addresses this by eliminating out-of-pocket costs for follow-up diagnostic testing," Senator Deb Patterson told the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
